Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
POSTED
12-01-23
Video: Merging Discovery With Clinical Care at Ontario Institute for Cancer Research
In the middle of downtown Toronto, surrounded by major universities and hospitals, the Ontario Institute for Cancer Research (OICR) is working to better understand tumor biology and improve cancer care.
POSTED
11-08-23
The Race Results Are in—And So Is the Marine Genomic Data
It was Fabrice Amedeo’s fourth time sailing the Route de Rhum. The solo race runs 3542 nautical miles, from Guadeloupe in the Southern Caribbean to the port of Saint-Malo in France. He set out on November 9, 2022; if all went well, his 60-foot yacht, the Nexans – Art et Fenêtres.
POSTED
11-03-23
Aegis Writes a New Chapter on Pathogen Surveillance
Before SARS-CoV-2, Aegis Sciences Corporation was a small, well-established lab with a specific niche. Founded in 1990, the Nashville-based company focused on anti-doping testing and medication compliance.
POSTED
10-24-23
The Future of Sustainable Mining Belongs to the Microbe
For generations, the metals and minerals that the mining industry produces have been integral to improving quality of life. And the industry is on the cusp of a staggering increase in demand for materials critical for low-carbon and renewable energy technology.
POSTED
10-20-23
Illumina Included on 2023 List of 100 Best Corporate Citizens List
Illumina has been included on the 2023 100 Best Corporate Citizens list by 3BL Media, recognizing outstanding environmental, social, and governance (ESG) performance among the 1,000 largest U.S. public companies.
POSTED
10-19-23
What the Diagnostic Odyssey Looks Like—And How We Can End It
People unfamiliar with the world of rare diseases might assume that someone with a genetic disorder received their diagnosis at birth. Unfortunately, this is almost never the case.
POSTED
10-13-23
How Do Genetic Factors Play a Role in Chronic Pain and Opioid Use Disorder?
Emma Johnson, PhD, assistant professor of Psychiatry at Washington University School of Medicine in St. Louis, was thrilled to win Illumina’s Polygenic Risk Scores Research Grant Contest.
POSTED
10-11-23
Q&A: An Illumina Intern’s Shift From Academia to Industry
When Adee Newman started her summer as a research associate Intern at Illumina in June 2023, she had no prior industry experience. Originally from Palo Alto, California, she spent two years at De Anza College before transferring to University of California, San Diego (UCSD).
POSTED
09-28-23
Summiting Italy’s Stelvio Pass for Cancer Research
On September 2, 11 Illumina teammates embarked on a journey up the formidable Passo dello Stelvio as part of the Stelvio for Life charity event. As they cycled, walked, and even ran their way up this challenging mountain pass in the Italian Alps, they did so with a purpose.
POSTED
09-19-23
Yes, It’s Possible: Students Visit Illumina and See Their Potential Careers
Illumina recently hosted 16 San Diego students for an intensive two-week paid summer program, thanks to a partnership with local nonprofit SD2, which gives underrepresented students unique access to STEM education and mentorships.
